Various modulators of ferroptosis, including inhibitors and inducers, provide novel perspectives for addressing bone and joint disorders
Melatonin has clearly stronger evidence for sleep
Weve spent the last two years drawing on Nooms deep expertise in behavior change to create the ultimate GLP-1 companion program to solve the medications twin challenges, persistence and muscle-mass loss, while also driving enhanced weight loss outcomes
Prior to April 22, 2026, the FDA placed these peptides as Category 2 Bulk drug substances, which have since been nominated for the 503A compounding list
For individuals whose insurance doesn't cover GLP-1 medications or whose plans impose significant barriers to access, the direct-to-consumer model may provide faster, more reliable access
Effects of Half- or Whole-Night Shifts on Physiological and Cognitive Parameters in Women